The role of ATM in breast cancer development

Jana Prokopcova1, Zdenek Kleibl, Claire M Banwell

  • 1Department of Biochemistry and Experimental Oncology, First Faculty of Medicine, Charles University, Prague, Czech Republic. jproko@lf1.cuni.cz

Insights

Individuals with mutations in the ataxia telangiectasia mutated (ATM) gene may face a higher risk of breast cancer. Research suggests ATM heterozygotes exhibit increased sensitivity to DNA damage, linking them to elevated cancer susceptibility.

Area of Science:

  • Genetics
  • Oncology
  • DNA Repair

Background:

  • DNA damage sensing and repair are critical for preventing cancer.
  • The ataxia telangiectasia mutated (ATM) protein kinase is vital for responding to DNA double-strand breaks.
  • Mutations in the ATM gene cause ataxia telangiectasia (AT), a syndrome linked to increased cancer risk.

Purpose of the Study:

  • To investigate the association between ATM gene mutations and breast cancer risk.
  • To explore the role of ATM heterozygosity in cancer predisposition.
  • To consolidate evidence supporting an increased breast cancer risk in ATM heterozygotes.

Main Methods:

  • Review of epidemiological studies on AT relatives and breast cancer incidence.
  • In vitro analysis of DNA repair and radiosensitivity in heterozygous cells.
  • Clinical examination of ATM mutation frequency in high-risk breast cancer families.

Main Results:

  • Epidemiological data indicate a higher breast cancer risk in relatives of AT patients.
  • Cellular studies demonstrate hyperradiosensitivity in ATM heterozygous cells.
  • Clinical findings reveal an increased prevalence of ATM mutations in families with a history of breast cancer.

Conclusions:

  • ATM heterozygosity is increasingly recognized as a risk factor for breast cancer.
  • The cellular hyperradiosensitivity observed in heterozygotes supports their increased cancer susceptibility.
  • Further research into ATM's role in sporadic and familial breast cancer is warranted.

Related Concept Videos

The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...